The U.S. Food and Drug Administration (FDA) on Wednesday announced it’s looking for more information on technologies and innovative ways to more efficiently conduct clinical research. The use of smartphones and tablet devices to collect trial participant data seems to be of particular interest to FDA as it’s requesting more information on the challenges associated with collecting data on trial participants’ own devices, which FDA says may be used to access and respond to study-related questionnaires. ¬†(Zachary Brennan, Regulatory Focus)